Cancer associated plexin B1 mutations

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007210, C435S007230, C536S023100, C536S023500

Reexamination Certificate

active

07888007

ABSTRACT:
The present inventors have identified cancer associated mutations in plexinB1, which is a transmembrane receptor that mediates semaphorin signaling. The frequency of plexinB1 mutations, in particular in prostate and breast cancer, indicates that plexinB1 may be useful in the screening and diagnosis of cancer and as a drug target in the development of anti-cancer therapeutics.

REFERENCES:
patent: 2004/0005563 (2004-01-01), Mack et al.
patent: 2005/0047996 (2005-03-01), Vogelstein et al.
patent: 2006/0019256 (2006-01-01), Clarke et al.
patent: WO 01/54477 (2001-08-01), None
patent: WO 02/31209 (2002-04-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 03/031930 (2003-04-01), None
Taber's Cyclopedic Medical Dictionary (1985, F.A. Davis Company, Philadelphia, p. 274).
Busken, C et al, (Digestive Disease Week Abstracts and Itinerary Planner, 2003, abstract No:850).
Kaiser (Science, 2006, 313, 1370).
Krontiris and Capizzi (Internal Medicine, 4th Edition, Editor-in-chief Jay Stein, Elsevier Science, 1994 Chapters 71-72, pp. 699-729).
Carter, S. K. et al. Chemotherapy of Cancer; Second edition; John Wiley & Sons : New York, 1981; appendix C.
Benedict et al (J. Exp. Medicine, 2001, 193(1) 89-99).
Jiang et al (J. Biol. Chem., 2003, 278(7) 4763-4769).
Matsushita et al (FEBS Letters, 1999, vol. 443, pp. 348-352).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
Dermer (Bio/Technology, 1994, 12: 320).
Drexler et al (Leukemia and Lymphoma, 1993, 9:1-25).
Zellner et al (Clin. Can. Res., 1998, 4:1797-1802).
Zips et al (In vivo, 2005, 19:1-7).
Giordano S. et al, “The semaphoring 4D receptor controls invasive growth by coupling with Met.” Nat Cell Biol. 2002 Sep; 4(9):720-724.
Aurandt et al, Proceedings of the National Academy of Sciences, Sep. 17, 2002, vol. 99, No. 19, pp. 12085-12090.
Haga et al, Journal of Human Genetics, 2002, vol. 47, No. 11, pp. 605-610.
Buetow et al, Nature Genetics, Mar. 1999, vol. 21, pp. 323-325.
Stratton et al, Nature 458:719-724, 2009 “The Cancer Genome”.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cancer associated plexin B1 mutations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer associated plexin B1 mutations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer associated plexin B1 mutations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2641617

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.